Brief: Ambu Q2 Organic Revenue Growth At 11.7%

Ambu A/S

07/05/2025 06:14

May 7 (Reuters) - Ambu A/S AMBUb.CO:

Q2 11.7% ORGANIC REVENUE GROWTH

Q2 14.4% EBIT MARGIN BEFORE SPECIAL ITEMS

Q2 REVENUE INCREASED ORGANICALLY BY 11.7% (15.5%) TO DKK 1,554M (DKK 1,367M)

Q2 EBIT BEFORE SPECIAL ITEMS (B.S.I.) WAS DKK 224M (DKK 194M)

2024/25 FINANCIAL GUIDANCE IS MAINTAINED

WITH TODAY’S STATUS ON TARIFFS, WE REMAIN CONFIDENT THAT WE WILL DELIVER ON OUR 2024/25 GUIDANCE

Q2 ENDOSCOPY SOLUTIONS BUSINESS INCREASED ORGANICALLY BY 13.1% (22.3%)

Q2 ANAESTHESIA & PATIENT MONITORING BUSINESS INCREASED ORGANICALLY BY 9.8% (7.0%)

Source text: (Full story)

Further company coverage: [AMBUb.CO]

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))